XTNT Announces Registered Direct Offering
January 13, 2017 17:41 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA
January 11, 2017 09:19 ET
|
Xtant Medical Holdings, Inc.
Record Fourth Quarter 2016 Revenue is estimated to be at least $24.5 million which represents 10.0% year on year growthFull Year 2016 Revenue is estimated to be at least $90.0 million which represents...
Xtant Medical Receives FDA Clearance for the Xsert™ Lumbar Expandable Interbody System
November 23, 2016 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 23, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million
November 17, 2016 15:42 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
Xtant Medical Announces Expiration of Rights Offering and Estimated Gross Proceeds of $3.8 Million
November 15, 2016 11:25 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
Xtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C™ Cervical Cage
November 15, 2016 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant Medical Announces First Surgical Cases of Xspan™ Laminoplasty Fixation System
November 14, 2016 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant Medical Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period and Final Subscription Price
November 11, 2016 13:09 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
Xtant Medical Announces Adjustment to Subscription Price of Rights Offering
November 09, 2016 09:18 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
Xtant™ Medical Holdings Reports Record Third Quarter 2016 Results
November 07, 2016 16:30 ET
|
Xtant Medical Holdings, Inc.
*See footnote about the use of pro forma financial information Third Quarter 2016 Highlights: Company revenue increased 10.5% to $23.1 million, as compared to pro forma revenue of $20.9 million in...